Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 12 - 21 tags : Covid-19 save search
Novavax Announces Initiation of PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster Study
Published: 2021-12-21 (Crawled : 23:00) - prnewswire.com
NVAX | $4.15 -0.96% -0.96% 2.4M
|
Health Technology
|
| O: 0.11%
H: 1.0%
C: -4.17%
event-19 covid-19 trial covid vaccine phase 3
CDC Publishes AXIM® Biotechnologies-Sponsored Study on COVID-19 Neutralizing Antibodies
Published: 2021-12-21 (Crawled : 15:30) - biospace.com/
AXIM | $0.0109 -6.67% 1.1M
|
Manufacturing
|
| O: 1.94%
H: 4.13%
C: -6.67%
covid-19 axim covid pons biotech iot antibody
First-of-its-kind Cue Health Partnership with Air Canada Provides U.S.-based Customers with Special Access to the Most Accurate COVID-19 Self-Test
Published: 2021-12-21 (Crawled : 15:30) - prnewswire.com
HLTH | $0.1488 -0.8% -0.81% 250K
|
|
| O: 3.33%
H: 1.23%
C: -9.96%
covid-19 partnership health air covid test
CytoDyn Receives Positive Response From FDA in Regard to its Phase 3, Registrational Trial in COVID-19 Critically Ill Population
Published: 2021-12-21 (Crawled : 14:30) - biospace.com/
CYDY | $0.15 0.06% 420K
|
Manufacturing
|
| O: 5.0%
H: 2.86%
C: 0.0%
covid-19 fda trial covid positive pons phase 3 response
Aridis Pharmaceuticals Announces a Pan-Coronavirus Monoclonal Antibody Cocktail That Retains Effectiveness Against the Omicron variant, other COVID-19 Variants, SARS, MERS, and the Common Cold Human Coronaviruses
Published: 2021-12-21 (Crawled : 11:00) - prnewswire.com
ARDS | $0.0635 2.82% 150K
|
Health Technology
|
| O: 60.24%
H: 6.63%
C: -31.7%
covid-19 als covid antibody
European Commission Expands Indication for Veklury (Remdesivir) for the Treatment of Adults Not on Supplemental Oxygen and Considered High Risk for COVID-19 Disease Progression
Published: 2021-12-21 (Crawled : 11:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.0%
H: 0.17%
C: -0.87%
covid-19 treatment europe risk oxygen covid disease
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.